2024-2025 PMHNP Review Course Manual
Please see corrections below in bold and red.
Chapter 14: Psychopharmacology: Antidepressants
Page 192:
Escitalopram (Lexapro):
Indications
FDA-approved for:
- Major Depressive Disorder (MDD) in adults and adolescents aged 12-17 years
- Generalized Anxiety Disorder (GAD) in adults
- Social Anxiety Disorder (SAD) (Changed to off-label)
- Panic Disorder (PD) in adults (Changed to off-label)
- Obsessive-Compulsive Disorder (OCD) in adults and adolescents aged 12-17 years (Changed to off-label)
Page 193:
Fluvoxamine (Luvox):
Indications
FDA-approved for:
- Obsessive-Compulsive Disorder (OCD) in adults and pediatric patients aged 8-17 years.
- Social Anxiety Disorder (SAD) in adults and pediatric patients aged 8 to 17 years. (Changed to off-label)